Acquired C1 esterase-inhibitor deficiency: case report with emphasis on complement and kallikrein activation during two patterns of clinical manifestations
View abstract on PubMed
Summary
This summary is machine-generated.This case study details a patient with acquired C1 inhibitor deficiency experiencing severe angioedema. The study highlights prekallikrein activation as a potential cause of symptoms in this condition.
Area Of Science
- Immunology
- Hematology
Background
- Presents a rare case of severe angioedema over 7 years.
- Characterized by acquired C1 inhibitor deficiency (C1 INH).
- No definitive lymphoproliferative malignancy or immune-complex disease identified initially.
Observation
- Patient developed a monoclonal IgG lambda-gammopathy.
- Edematous attacks ceased, replaced by digestive and vasomotor symptoms.
- Worsening complement abnormalities observed over time.
Findings
- Digestive and vasomotor attacks correlated with prekallikrein and high-molecular-weight kininogen consumption.
- Demonstrates activation of the prekallikrein pathway in acquired C1 INH deficiency.
- Suggests bradykinin and related products contribute to clinical manifestations.
Implications
- Provides insight into the pathophysiology of acquired C1 INH deficiency.
- Suggests therapeutic targets within the kinin-kallikrein pathway.
- Highlights the evolving clinical presentation of this disorder.